Active Biotech AB (publ) BTPC.F Stock
Active Biotech AB (publ) Price Chart
Active Biotech AB (publ) BTPC.F Financial and Trading Overview
| Active Biotech AB (publ) stock price | 0.03 EUR |
| Previous Close | 0.06 EUR |
| Open | 0.06 EUR |
| Bid | 0.06 EUR x 214100 |
| Ask | 0.08 EUR x 205900 |
| Day's Range | 0.06 - 0.06 EUR |
| 52 Week Range | 0.04 - 0.13 EUR |
| Volume | 12.5K EUR |
| Avg. Volume | 986 EUR |
| Market Cap | 15.62M EUR |
| Beta (5Y Monthly) | 0.468965 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BTPC.F Valuation Measures
| Enterprise Value | 18.61M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7853333 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Active Biotech AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.468965 |
| 52-Week Change | -10.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.13 EUR |
| 52 Week Low | 0.04 EUR |
| 50-Day Moving Average | 0.06 EUR |
| 200-Day Moving Average | 0.07 EUR |
BTPC.F Share Statistics
| Avg. Volume (3 month) | 986 EUR |
| Avg. Daily Volume (10-Days) | 1.55K EUR |
| Shares Outstanding | 265.14M |
| Float | 187.23M |
| Short Ratio | N/A |
| % Held by Insiders | 45.09% |
| % Held by Institutions | 15.87% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -83.26% |
| Return on Equity (ttm) | -200.63% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 17.83 EUR |
| Current Ratio (mrq) | 2.661 |
| Book Value Per Share (mrq) | 0.075 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Active Biotech AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Scheelevägen 22 |
| ZIP | 223 63 |
| Phone | 46 46 19 20 00 |
| Website | https://www.activebiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Biotech AB (publ) was incorporated in 1983 and is headquartered in Lund, Sweden.
Q&A For Active Biotech AB (publ) Stock
What is a current BTPC.F stock price?
Active Biotech AB (publ) BTPC.F stock price today per share is 0.03 EUR.
How to purchase Active Biotech AB (publ) stock?
You can buy BTPC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Active Biotech AB (publ)?
The stock symbol or ticker of Active Biotech AB (publ) is BTPC.F.
Which industry does the Active Biotech AB (publ) company belong to?
The Active Biotech AB (publ) industry is Biotechnology.
How many shares does Active Biotech AB (publ) have in circulation?
The max supply of Active Biotech AB (publ) shares is 473.97M.
What is Active Biotech AB (publ) Price to Earnings Ratio (PE Ratio)?
Active Biotech AB (publ) PE Ratio is now.
What was Active Biotech AB (publ) earnings per share over the trailing 12 months (TTM)?
Active Biotech AB (publ) EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Active Biotech AB (publ) company belong to?
The Active Biotech AB (publ) sector is Healthcare.